Aeolus Pharmaceuticl Stock Buy Hold or Sell Recommendation
| AOLS Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Aeolus Pharmaceuticl is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aeolus Pharmaceuticl given historical horizon and risk tolerance towards Aeolus Pharmaceuticl. When Macroaxis issues a 'buy' or 'sell' recommendation for Aeolus Pharmaceuticl, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Aeolus Pharmaceuticl Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aeolus and provide practical buy, sell, or hold advice based on investors' constraints. Aeolus Pharmaceuticl. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Aeolus |
Execute Aeolus Pharmaceuticl Buy or Sell Advice
The Aeolus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aeolus Pharmaceuticl. Macroaxis does not own or have any residual interests in Aeolus Pharmaceuticl or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aeolus Pharmaceuticl's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Aeolus Pharmaceuticl Trading Alerts and Improvement Suggestions
| Aeolus Pharmaceuticl generated a negative expected return over the last 90 days | |
| Aeolus Pharmaceuticl has some characteristics of a very speculative penny stock | |
| Aeolus Pharmaceuticl has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.08 M. Net Loss for the year was (3.56 M) with loss before overhead, payroll, taxes, and interest of (805 K). | |
| Aeolus Pharmaceuticl currently holds about 403 K in cash with (3.11 M) of positive cash flow from operations. |
Aeolus Pharmaceuticl Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aeolus Pharmaceuticl or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aeolus Pharmaceuticl's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aeolus pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Aeolus Pharmaceuticl Volatility Alert
At this time Aeolus Pharmaceuticl exhibits very low volatility. Aeolus Pharmaceuticl appears to be a penny stock. Although Aeolus Pharmaceuticl may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Aeolus Pharmaceuticl or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aeolus instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aeolus Pharmaceuticl Fundamentals Vs Peers
Comparing Aeolus Pharmaceuticl's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aeolus Pharmaceuticl's direct or indirect competition across all of the common fundamentals between Aeolus Pharmaceuticl and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aeolus Pharmaceuticl or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Aeolus Pharmaceuticl's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aeolus Pharmaceuticl by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aeolus Pharmaceuticl to competition |
| Fundamentals | Aeolus Pharmaceuticl | Peer Average |
| Return On Equity | -1.86 | -0.31 |
| Return On Asset | -0.9 | -0.14 |
| Operating Margin | (5.31) % | (5.51) % |
| Current Valuation | 167.29 K | 16.62 B |
| Shares Outstanding | 152.09 M | 571.82 M |
| Price To Earning | (2.37) X | 28.72 X |
| Price To Book | 0.81 X | 9.51 X |
| Price To Sales | 0.22 X | 11.42 X |
| Revenue | 2.08 M | 9.43 B |
| Gross Profit | (805 K) | 27.38 B |
| EBITDA | (3.85 M) | 3.9 B |
| Net Income | (3.56 M) | 570.98 M |
| Cash And Equivalents | 403 K | 2.7 B |
| Debt To Equity | 0.30 % | 48.70 % |
| Current Ratio | 1.30 X | 2.16 X |
| Book Value Per Share | 0 X | 1.93 K |
| Cash Flow From Operations | (3.11 M) | 971.22 M |
| Earnings Per Share | (0.03) X | 3.12 X |
| Target Price | 1.25 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | -3.96 | -0.15 |
| Market Capitalization | 167.29 K | 19.03 B |
| Total Asset | 4.17 M | 29.47 B |
| Retained Earnings | (184.68 M) | 9.33 B |
| Working Capital | 3.16 M | 1.48 B |
| Current Asset | 4.13 M | 9.34 B |
| Current Liabilities | 972 K | 7.9 B |
| Z Score | -61.6 | 8.72 |
| Net Asset | 4.17 M |
Aeolus Pharmaceuticl Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aeolus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Aeolus Pharmaceuticl Buy or Sell Advice
When is the right time to buy or sell Aeolus Pharmaceuticl? Buying financial instruments such as Aeolus Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aeolus Pharmaceuticl in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cryptocurrency Thematic Idea Now
Cryptocurrency
Dynamically computed list of top cryptocurrencies sorted bymarket capitalization. The Cryptocurrency theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cryptocurrency Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aeolus Pink Sheet Analysis
When running Aeolus Pharmaceuticl's price analysis, check to measure Aeolus Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aeolus Pharmaceuticl is operating at the current time. Most of Aeolus Pharmaceuticl's value examination focuses on studying past and present price action to predict the probability of Aeolus Pharmaceuticl's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aeolus Pharmaceuticl's price. Additionally, you may evaluate how the addition of Aeolus Pharmaceuticl to your portfolios can decrease your overall portfolio volatility.